ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GWAV vs TMO // GROSS PROFIT MARGIN

Greenwave Technology Solutions Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: GWAV 2 — TMO 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GWAV VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GWAV TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 9.30% -44.30 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield — 2.40% — TIE /fcf-yield <GO>
Operating Margin -42.50% 17.40% -59.90 TMO /operating-margins <GO>
Net Profit Margin 52.70% 15.10% +37.60 GWAV /net-margins <GO>
Revenue Growth (YoY) 40.10% 3.90% +36.20 GWAV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 4.50 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 32.2 62.9 -30.72 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $6.1M $262.22B -$262.21B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GWAV REV TMO REV GWAV GROSS % TMO GROSS % GWAV FCF TMO FCF
FY 2025 $46.7M $44.56B 25.4% — -$6.0M $6.29B
FY 2024 $33.3M $42.88B 39.0% — -$17.3M $7.27B
FY 2023 $35.7M $42.86B — — -$1.8M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GWAV // BETA —
TMO // BETA 0.94